Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Sernova Corp > Shorts
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(62)
•••
Comment by JonEcashon Feb 22, 2021 10:13pm
181 Views
Post# 32633754

RE:RE:RE:RE:Shorts

RE:RE:RE:RE:Shorts

I don't believe these latest financing units have a hold period. Such a 3-4 month hold is usually explicitly stated in the NR.  Can anyone else confirm?

Even if the sp were to drop 20 cents (which I don't think will happen), we would still be trading well above the deal price. Which a very strong sign. Not to mention the volumes are pretty low, meaning there's not much more to shake free. I expect hearing of the closed, oversubscribed financing this week so that the news flow can restart our upward trend. The other positive of these past few weeks, has been the unwinding of the overbought indicators in both the daily and weekly charts. 

GLTA!

J$

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities